AAPS Names Dr Rod Rohrich 2026 Clinician of the Year
The award highlights Rohrich’s decades-long involvement in academic publishing, surgical training, and leadership roles across the plastic surgery specialty.
The award highlights Rohrich’s decades-long involvement in academic publishing, surgical training, and leadership roles across the plastic surgery specialty.
The product is the first botulinum toxin type E approved for aesthetic use and is designed to deliver faster onset and shorter-lasting results than traditional neurotoxins.